Clin2
NCT07287345Possibly a fitRecruiting

Colchicine’s effect on inflammation after heart bypass surgery

ColchicineInflammation in Cardiac SurgeryPost Operative Atrial FibrillationInflammatory MarkersColchicine Adverse Reaction

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether the drug colchicine can reduce inflammation after planned coronary artery bypass graft (CABG) surgery. It may help patients recover better by lowering inflammatory markers.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
24 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You are scheduled to have planned (not emergency) coronary artery bypass graft (CABG) surgery.
  • You do not have a history of atrial fibrillation.
  • You are not currently taking colchicine, and you have no known allergy to colchicine.
  • You do not have severe liver, kidney, muscle, or intestinal disease, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07569328Not yet recruiting
Low-dose colchicine after heart bypass surgery

This trial tests whether taking a low dose of colchicine, an anti-inflammatory medicine, after heart bypass surgery can help keep the new blood vessels open and working well. It may help reduce the chance of the bypass grafts failing.

Beijing, Beijing Municipality
NCT06802926Recruiting· Phase 4
Colchicine to prevent graft failure after bypass surgery

This study tests whether a low dose of colchicine, an anti-inflammatory drug, can help prevent the graft (new blood vessel) from failing after heart bypass surgery. It's for people who just had a bypass and are still in the hospital.

Shanghai
NCT06215989Recruiting
Low-dose colchicine for acute coronary syndrome

This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.

Beijing, Beijing Municipality
NCT06118034Recruiting· Phase 3
Colchicine for heart surgery recovery

This study tests whether the drug colchicine can reduce inflammation and protect organs during and after planned heart surgery. It may help people recover better.

Nanjing, Jiangsu
NCT07611019Enrolling by invitation· Phase 2/Phase 3
Colchicine to prevent heart rhythm problems after heart bypass surgery

This study tests whether taking colchicine (a common anti-inflammatory medication) before and after bypass heart surgery can prevent atrial fibrillation—an irregular heartbeat that sometimes occurs after surgery. Researchers hope this simple treatment might reduce complications and improve recovery.

Taipei
NCT05618353Recruiting· Phase 4
Colchicine before surgery to lower heart and inflammation complications

This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.

Birmingham, Alabama

Hear when a new Colchicine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.